Doximity's stock surges on medical AI excitement as analysts debate long-term risks

Doximity's stock surges on medical AI excitement as analysts debate long-term risks

Doximity stock surged 43% after Q1: 300k active AI users, 50% of US client hospital physicians using workflow tools. Risk: if AI adoption cannibalizes advertising revenue, revenue per user could decline—a red flag for vendor selection and long-term viability.